CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981034922
- Phone
- (929) 274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- 4 Grant or award Director acquired 12,312 shares (grant or award)
- 4 Grant or award Director acquired 23,409 shares (grant or award)
- 4 Grant or award Director acquired 16,413 shares (grant or award)
- 4 Grant or award Director acquired 17,777 shares (grant or award)
- 4 Option exercise CEO acquired 27,066 shares (option exercise)
- 4 Grant or award Director acquired 8,536 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CEO acquired 6,430 shares (grant or award)
- 4 Grant or award Interim CFO acquired 1,728 shares (grant or award)
- 4 Grant or award Interim CFO acquired 1,130 shares (grant or award)
- 4 Option exercise Director acquired 22,474 shares (option exercise)
- 4 Grant or award Interim CFO acquired 18,830 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 7 · 131 filings